Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 574

1.

Enzootic patterns of Middle East respiratory syndrome coronavirus in imported African and local Arabian dromedary camels: a prospective genomic study.

El-Kafrawy SA, Corman VM, Tolah AM, Al Masaudi SB, Hassan AM, Müller MA, Bleicker T, Harakeh SM, Alzahrani AA, Alsaaidi GA, Alagili AN, Hashem AM, Zumla A, Drosten C, Azhar EI.

Lancet Planet Health. 2019 Dec;3(12):e521-e528. doi: 10.1016/S2542-5196(19)30243-8. Epub 2019 Dec 16.

2.

PET/CT features of Extrapulmonary Tuberculosis at first clinical presentation - a cross-sectional observational 18F-FDG imaging study across six countries.

Bomanji J, Sharma R, Mittal BR, Gambhir S, Qureshy A, Begum SMF, Paez D, Sathekge M, Vorster M, Sobic Saranovic D, Pusuwan P, Mann V, Vinjamuri S, Zumla A, Pascual TNB; International Atomic Energy Agency Extra-pulmonary TB Consortium.

Eur Respir J. 2019 Dec 12. pii: 1901959. doi: 10.1183/13993003.01959-2019. [Epub ahead of print]

PMID:
31831584
3.

Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patients.

Mukonzo JK, Kengo A, Kutesa B, Nanzigu S, Pohanka A, McHugh TD, Zumla A, Aklillu E.

Trans R Soc Trop Med Hyg. 2019 Dec 2. pii: trz108. doi: 10.1093/trstmh/trz108. [Epub ahead of print]

PMID:
31789383
4.

Emerging and Reemerging Infectious Diseases: Global Overview.

Zumla A, Hui DSC.

Infect Dis Clin North Am. 2019 Dec;33(4):xiii-xix. doi: 10.1016/j.idc.2019.09.001. No abstract available.

PMID:
31668202
5.

Viral Hemorrhagic Fevers Other than Ebola and Lassa.

Iannetta M, Di Caro A, Nicastri E, Vairo F, Masanja H, Kobinger G, Mirazimi A, Ntoumi F, Zumla A, Ippolito G.

Infect Dis Clin North Am. 2019 Dec;33(4):977-1002. doi: 10.1016/j.idc.2019.08.003. Review.

PMID:
31668201
6.

Ebola Virus Disease: Epidemiology, Clinical Features, Management, and Prevention.

Nicastri E, Kobinger G, Vairo F, Montaldo C, Mboera LEG, Ansunama R, Zumla A, Ippolito G.

Infect Dis Clin North Am. 2019 Dec;33(4):953-976. doi: 10.1016/j.idc.2019.08.005. Review.

PMID:
31668200
7.

Lassa Fever: Epidemiology, Clinical Features, Diagnosis, Management and Prevention.

Asogun DA, Günther S, Akpede GO, Ihekweazu C, Zumla A.

Infect Dis Clin North Am. 2019 Dec;33(4):933-951. doi: 10.1016/j.idc.2019.08.002. Review.

PMID:
31668199
8.

The Middle East Respiratory Syndrome (MERS).

Azhar EI, Hui DSC, Memish ZA, Drosten C, Zumla A.

Infect Dis Clin North Am. 2019 Dec;33(4):891-905. doi: 10.1016/j.idc.2019.08.001. Review.

PMID:
31668197
9.

Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features.

Hui DSC, Zumla A.

Infect Dis Clin North Am. 2019 Dec;33(4):869-889. doi: 10.1016/j.idc.2019.07.001. Review.

PMID:
31668196
10.

Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and Treatment.

Tiberi S, Zumla A, Migliori GB.

Infect Dis Clin North Am. 2019 Dec;33(4):1063-1085. doi: 10.1016/j.idc.2019.09.002. Review.

PMID:
31668191
11.

Viral Hepatitis: Etiology, Epidemiology, Transmission, Diagnostics, Treatment, and Prevention.

Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G.

Infect Dis Clin North Am. 2019 Dec;33(4):1045-1062. doi: 10.1016/j.idc.2019.08.004. Review.

PMID:
31668190
12.

Chikungunya: Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention.

Vairo F, Haider N, Kock R, Ntoumi F, Ippolito G, Zumla A.

Infect Dis Clin North Am. 2019 Dec;33(4):1003-1025. doi: 10.1016/j.idc.2019.08.006. Review.

PMID:
31668189
13.

Rescue of Replication-Competent ZIKV Hidden in Placenta-Derived Mesenchymal Cells Long After the Resolution of the Infection.

Bordoni V, Lalle E, Colavita F, Baiocchini A, Nardacci R, Falasca L, Carletti F, Cimini E, Bordi L, Kobinger G, D'Ambrosio V, Natale F, Giancotti A, Manganaro L, Del Nonno F, Zumla A, Liuzzi G, Ippolito G, Capobianchi MR, Agrati C, Castilletti C.

Open Forum Infect Dis. 2019 Oct 9;6(10):ofz342. doi: 10.1093/ofid/ofz342. eCollection 2019 Oct.

14.

Vaccine against Middle East respiratory syndrome coronavirus.

Zumla A, Memish ZA, Hui DS, Perlman S.

Lancet Infect Dis. 2019 Oct;19(10):1054-1055. doi: 10.1016/S1473-3099(19)30477-3. No abstract available.

PMID:
31559955
15.

Urogenital tuberculosis - epidemiology, pathogenesis and clinical features.

Muneer A, Macrae B, Krishnamoorthy S, Zumla A.

Nat Rev Urol. 2019 Oct;16(10):573-598. doi: 10.1038/s41585-019-0228-9. Epub 2019 Sep 23. Review.

PMID:
31548730
16.

Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials.

Lanini S, Ioannidis JPA, Vairo F, Pletschette M, Portella G, Di Bari V, Mammone A, Pisapia R, Merler S, Nguhuni B, Langer M, Di Caro A, Edwards SJL, Petrosillo N, Zumla A, Ippolito G.

Lancet Infect Dis. 2019 Dec;19(12):e444-e451. doi: 10.1016/S1473-3099(19)30284-1. Epub 2019 Aug 23. Review.

PMID:
31451421
17.

Pulmonary Involvement during the Ebola Virus Disease.

Lalle E, Biava M, Nicastri E, Colavita F, Di Caro A, Vairo F, Lanini S, Castilletti C, Langer M, Zumla A, Kobinger G, Capobianchi MR, Ippolito G.

Viruses. 2019 Aug 24;11(9). pii: E780. doi: 10.3390/v11090780. Review.

18.

Risk of antibiotic resistant meningococcal infections in Hajj pilgrims.

Zumla A, Memish ZA.

BMJ. 2019 Aug 23;366:l5260. doi: 10.1136/bmj.l5260. No abstract available.

PMID:
31444169
19.

A One-Health lens for anthrax.

Kock R, Haider N, Mboera LE, Zumla A.

Lancet Planet Health. 2019 Jul;3(7):e285-e286. doi: 10.1016/S2542-5196(19)30111-1. No abstract available.

20.

Early improvement of glycaemic control after virus clearance in patients with chronic hepatitis C and severe liver fibrosis: a cohort study.

Lanini S, Bartolini B, Taibi C, Agresta A, Garbuglia AR, Montaldo C, Pisapia R, D'Offizi G, Scognamiglio P, Capobianchi MR, Zumla A, Ippolito G.

New Microbiol. 2019 Jul;42(3):139-144. Epub 2019 Jul 15.

21.

Confronting the persisting threat of the Middle East respiratory syndrome to global health security.

Perlman S, Azhar EI, Memish ZA, Hui DS, Zumla A.

Lancet Infect Dis. 2019 Jul 3. pii: S1473-3099(19)30347-0. doi: 10.1016/S1473-3099(19)30347-0. [Epub ahead of print] No abstract available.

PMID:
31279728
22.

High-income countries and latent tuberculosis infection screening for migrants - Authors' reply.

Petersen E, Chakaya J, Jawad FM, Ippolito G, Zumla A.

Lancet Infect Dis. 2019 Jul;19(7):691-692. doi: 10.1016/S1473-3099(19)30283-X. No abstract available.

PMID:
31250815
23.

Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies.

Rao M, Dodoo E, Zumla A, Maeurer M.

Front Microbiol. 2019 May 7;10:962. doi: 10.3389/fmicb.2019.00962. eCollection 2019. Review.

24.

Mass gatherings medicine: public health issues arising from mass gathering religious and sporting events.

Memish ZA, Steffen R, White P, Dar O, Azhar EI, Sharma A, Zumla A.

Lancet. 2019 May 18;393(10185):2073-2084. doi: 10.1016/S0140-6736(19)30501-X. Review.

PMID:
31106753
25.

Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention.

Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, Zumla A.

Infect Dis Clin North Am. 2019 Dec;33(4):1027-1043. doi: 10.1016/j.idc.2019.03.001. Epub 2019 Apr 11. Review.

PMID:
30981594
26.

Editorial: Toward improving the diagnosis, treatment and prevention of community acquired and nosocomial respiratory tract infections.

Niederman MS, Zumla A.

Curr Opin Pulm Med. 2019 May;25(3):217-219. doi: 10.1097/MCP.0000000000000577. No abstract available.

PMID:
30920457
27.

Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease.

Tembo J, Simulundu E, Changula K, Handley D, Gilbert M, Chilufya M, Asogun D, Ansumana R, Kapata N, Ntoumi F, Ippolito G, Zumla A, Bates M.

Expert Rev Mol Diagn. 2019 Apr;19(4):325-340. doi: 10.1080/14737159.2019.1595592. Epub 2019 Apr 5.

PMID:
30916590
28.

After the UNGA High-Level Meeting on Tuberculosis-what next and how?

Sahu S, Ditiu L, Zumla A.

Lancet Glob Health. 2019 May;7(5):e558-e560. doi: 10.1016/S2214-109X(19)30068-3. Epub 2019 Mar 12. No abstract available.

29.

Revolutionary new treatment regimens for multidrug-resistant tuberculosis.

McHugh TD, Honeyborne I, Lipman M, Zumla A.

Lancet Infect Dis. 2019 Mar;19(3):233-234. doi: 10.1016/S1473-3099(19)30060-X. No abstract available.

PMID:
30833051
30.

Latent tuberculosis infection: diagnostic tests and when to treat.

Petersen E, Chakaya J, Jawad FM, Ippolito G, Zumla A.

Lancet Infect Dis. 2019 Mar;19(3):231-233. doi: 10.1016/S1473-3099(19)30059-3. No abstract available.

PMID:
30833050
31.

Isoniazid preventive therapy for children in sub-Saharan Africa.

Meremikwu M, Zumla A.

Lancet Respir Med. 2019 Mar;7(3):197-199. doi: 10.1016/S2213-2600(19)30037-2. No abstract available.

PMID:
30823970
32.

Towards optimal treatment for latent Mycobacterium tuberculosis infection.

Abubakar I, Chakaya J, Maeurer M, Zumla A.

Lancet Respir Med. 2019 Mar;7(3):195-197. doi: 10.1016/S2213-2600(19)30036-0. No abstract available.

PMID:
30823969
33.

Latent TB Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground.

Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M.

Int J Infect Dis. 2019 Mar;80S:S58-S61. doi: 10.1016/j.ijid.2019.02.035. Epub 2019 Feb 26.

34.

World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series.

Petersen E, Rao M, Ippolito G, Gualano G, Chakaya J, Ntoumi F, Moore D, Allen R, Gaskell K, Öhd JN, Hergens MP, Krishnamoorthy S, Ugarte-Gil C, Kirwan DE, Honeyborne I, McHugh TD, Köser CU, Kranzer K, Tiberi S, Migliori GB, Mao Q, Yang Y, Oliveira SP, Cardoso RF, Detjen A, Marais B, de Gijsel D, von Reyn CF, Goscé L, Abubakar I, Maeurer M, Zumla A.

Int J Infect Dis. 2019 Mar;80S:S1-S5. doi: 10.1016/j.ijid.2019.02.024. Epub 2019 Feb 23. No abstract available.

35.

The changing treatment landscape for MDR/XDR-TB - Can current clinical trials revolutionise and inform a brave new world?

Honeyborne I, Lipman M, Zumla A, McHugh TD.

Int J Infect Dis. 2019 Mar;80S:S23-S28. doi: 10.1016/j.ijid.2019.02.006. Epub 2019 Feb 15. No abstract available.

36.

Latent tuberculosis infection and renal transplantation - Diagnosis and management.

Krishnamoorthy S, Kumaresan N, Zumla A.

Int J Infect Dis. 2019 Mar;80S:S73-S76. doi: 10.1016/j.ijid.2019.01.049. Epub 2019 Feb 6.

37.

Tuberculin skin test - Outdated or still useful for Latent TB infection screening?

Gualano G, Mencarini P, Lauria FN, Palmieri F, Mfinanga S, Mwaba P, Chakaya J, Zumla A, Ippolito G.

Int J Infect Dis. 2019 Mar;80S:S20-S22. doi: 10.1016/j.ijid.2019.01.048. Epub 2019 Feb 6. Review.

38.

Transmission and prevention of acute viral respiratory tract infections in hospitals.

Wilson P, Zumla A.

Curr Opin Pulm Med. 2019 May;25(3):220-224. doi: 10.1097/MCP.0000000000000566.

PMID:
30730312
39.

Improving treatment outcomes for MDR-TB - Novel host-directed therapies and personalised medicine of the future.

Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M.

Int J Infect Dis. 2019 Mar;80S:S62-S67. doi: 10.1016/j.ijid.2019.01.039. Epub 2019 Jan 24.

40.

RESPIRE: The National Institute for Health Research's (NIHR) Global Respiratory Health Unit.

Sheikh A, Campbell H, Balharry D, Baqui AH, Bogaert D, Cresswell K, Cunningham S, Dockerell D, El Arifeen S, Fletcher M, Grant L, Ghazali SS, Habib M, Hazir T, Isaac R, Juvekar S, Khoo EM, McKinstry B, Morris AD, Nair H, Norrie J, Nwaru BI, Pinnock H, Robertson D, Saha S, Salvi S, Schwarze J, Simpson C, Sridhar D, Stoddart A, Weller D, Whyte M, Worth A, Williams S, Yusuf O, Zumla A, Rudan I; RESPIRE Collaboration.

J Glob Health. 2018 Dec;8(2):020101. doi: 10.7189/jogh.08.020101. No abstract available.

41.

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants.

Zumla A, Abubakar I.

BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0.

42.

Universal health coverage for refugees and migrants in the twenty-first century.

Abubakar I, Zumla A.

BMC Med. 2018 Nov 26;16(1):216. doi: 10.1186/s12916-018-1208-2.

43.

Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era.

Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh TD, Ippolito G, Zumla A.

Int J Infect Dis. 2019 Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018 Nov 16. Review.

44.

Achieving sustainable development goals for HIV/AIDS in the Republic of the Congo - Progress, obstacles and challenges in HIV/AIDS health services.

Ghoma Linguissi LS, Lucaccioni V, Bates M, Zumla A, Ntoumi F.

Int J Infect Dis. 2018 Dec;77:107-112. doi: 10.1016/j.ijid.2018.10.009. Epub 2018 Oct 17. Review.

45.

Advancing global tuberculosis control after the UNGA-HLM.

Marais B, Zumla A.

Lancet. 2018 Sep 29;392(10153):1096-1097. doi: 10.1016/S0140-6736(18)32361-4. Epub 2018 Sep 24. No abstract available.

PMID:
30262331
46.

The historic and unprecedented United Nations General Assembly High Level Meeting on Tuberculosis (UNGA-HLM-TB)-'United to End TB: An Urgent Global Response to a Global Epidemic'.

Zumla A, Petersen E.

Int J Infect Dis. 2018 Oct;75:118-120. doi: 10.1016/j.ijid.2018.09.017. Epub 2018 Sep 19. No abstract available.

47.

Effectiveness of service models and organisational structures supporting tuberculosis identification and management in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review.

Heuvelings CC, Greve PF, de Vries SG, Visser BJ, Bélard S, Janssen S, Cremers AL, Spijker R, Shaw E, Hill RA, Zumla A, Sandgren A, van der Werf MJ, Grobusch MP.

BMJ Open. 2018 Sep 8;8(9):e019642. doi: 10.1136/bmjopen-2017-019642.

48.

Children infected by human herpesvirus 6B with febrile seizures are more likely to develop febrile status epilepticus: A case-control study in a referral hospital in Zambia.

Tembo J, Chandwe K, Kabwe M, Chilufya M, Ciccone O, Mpabalwani E, Ablashi D, Zumla A, Chen T, Bates M.

J Med Virol. 2018 Nov;90(11):1757-1764. doi: 10.1002/jmv.25269. Epub 2018 Aug 13.

PMID:
30011348
49.

Tuberculosis series.

Silva DR, Mello FCQ, Kritski A, Dalcolmo M, Zumla A, Migliori GB.

J Bras Pneumol. 2018 Apr;44(2):71-72. doi: 10.1590/s1806-37562018000020001. English, Portuguese. No abstract available.

50.

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.

Silva DR, Dalcolmo M, Tiberi S, Arbex MA, Munoz-Torrico M, Duarte R, D'Ambrosio L, Visca D, Rendon A, Gaga M, Zumla A, Migliori GB.

J Bras Pneumol. 2018 Apr;44(2):153-160. doi: 10.1590/s1806-37562017000000436. Review. Portuguese, English.

Supplemental Content

Support Center